IRADIMED CORP 10-K/A

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market for Common Stock Our common stock was publicly traded under the stock symbol “IRMD” on the Nasdaq “Capital Market” from July 16, 2014 until June 13, 2024 and on the Nasdaq “Global Market” since June 14, 2024. Prior to July 16, 2014, there was no public market for our common stock. Stockholders As of February 28, 2025, we had 3 stockholders of record. This number does not include “street name” or beneficial holders, whose shares are held by banks, brokers, financial institutions and other nominees. Dividends On December 12, 2023, the Board of Directors declared the initiation of a regular quarterly dividend on the Company's outstanding common stock. On February 13, 2025, the Company announced that the Board increased our quarterly cash dividend from $0.15 to $0.17 per share. The decision on whether to pay, and the amount of cash dividends, if any, on our common stock in the future will be made by our Board of Directors, at its discretion, and will depend on our financial condition, operating results, capital requirements and other factors that the Board of Directors considers significant. ​ Unregistered Sales of Securities; Use of Proceeds from Registered Securities None. Purchases of Equity Securities by the Issuer The following table provides information regarding repurchases of common stock for the three months ended December 31, 2024. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Number Maximum ​ ​ ​ ​ ​ ​ ​ of Shares ​ Dollar Value of ​ ​ ​ ​ ​ ​ ​ Purchased as ​ Shares that ​ ​ Total ​ ​ ​ ​ Part of ​ May Yet ​ ​ Number of ​ ​ ​ ​ Publicly ​ Be Purchased ​ ​ Shares ​ Average Price ​ Announced ​ Under the ​ ​ Purchased ​ Paid per Share ​ Plans or ​ Plans or ​ (1) (2) Programs Programs October 1, 2024—October 31, 2024 337 $ — — $ — November 1, 2024—November 30, 2024 379 $ — — $ — December 1, 2024—December 31, 2024 9,329 $ — — $ — Total 10,045 $ — — $ — (1) The number of shares purchased reflects shares withheld for taxes on vesting of restricted stock. There were no shares repurchased pursuant to the open market repurchase authorization. (2) The average price paid per share does not include the withheld shares discussed in (1). Equity Compensation Plan Information The information required by this item regarding our equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report 40 Table of Contents Stock Performance Graph The following information of Part II Item 5 is being furnished and shall not be deemed to be “soliciting material” or to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section, nor will it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that we specifically incorporate such information by reference thereto. The following graph shows a comparison, from December 31, 2019 through December 31, 2024, of cumulative total return for our common stock, the Russell 2000 Index and the Nasdaq Medical Equipment Index. Such returns are based on historical results and are not intended to suggest future performance. Data for the Russell 2000 Index and the Nasdaq Medical Equipment Index assumes reinvestment of dividends. ​ ITEM 6. [RESERVED] ​ 41 Table of Contents